These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15870950)

  • 1. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.
    Suzuki K; Yano T; Sadzuka Y; Sugiyama T; Seki T; Asano R
    Oncol Rep; 2005 Jun; 13(6):1247-50. PubMed ID: 15870950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43.
    Saito T; Sato H; Virgona N; Hagiwara H; Kashiwagi K; Suzuki K; Asano R; Yano T
    Cancer Lett; 2007 Aug; 253(2):249-57. PubMed ID: 17343982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connexin 43-dependent tumor-suppressing effect of the Bowman-Birk protease inhibitor on M5076 ovarian sarcoma-bearing mice.
    Sakurai N; Suzuki K; Nagaoka T; Saito T; Yoshimura H; Yano T; Sadzuka Y; Asano R
    Mol Med Rep; 2008; 1(5):689-93. PubMed ID: 21479471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a single-dose administration of Bowman-Birk inhibitor concentrate on anti-proliferation and inhabitation of metastasis in M5076 ovarian sarcoma-bearing mice.
    Sakurai N; Suzuki K; Sano Y; Saito T; Yoshimura H; Nishimura Y; Yano T; Sadzuka Y; Asano R
    Mol Med Rep; 2008; 1(6):903-7. PubMed ID: 21479504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans.
    Evans SM; Van Winkle T; Szuhaj B; Michel KE; Kennedy AR
    Radiat Res; 1992 Nov; 132(2):259-62. PubMed ID: 1438709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor.
    St Clair WH; Billings PC; Carew JA; Keller-McGandy C; Newberne P; Kennedy AR
    Cancer Res; 1990 Feb; 50(3):580-6. PubMed ID: 2297699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective radioprotection of normal tissues by Bowman-birk proteinase inhibitor (BBI) in mice.
    Dittmann K; Toulany M; Classen J; Heinrich V; Milas L; Rodemann HP
    Strahlenther Onkol; 2005 Mar; 181(3):191-6. PubMed ID: 15756524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia.
    Armstrong WB; Kennedy AR; Wan XS; Atiba J; McLaren CE; Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):43-7. PubMed ID: 10667462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor.
    Tang M; Asamoto M; Ogawa K; Naiki-Ito A; Sato S; Takahashi S; Shirai T
    Pathol Int; 2009 Nov; 59(11):790-6. PubMed ID: 19883429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent.
    Ekrami H; Kennedy AR; Witschi H; Shen WC
    J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells.
    Wan XS; Hamilton TC; Ware JH; Donahue JJ; Kennedy AR
    Nutr Cancer; 1998; 31(1):8-17. PubMed ID: 9682243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
    Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR
    Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model.
    Kobayashi H; Fukuda Y; Yoshida R; Kanada Y; Nishiyama S; Suzuki M; Kanayama N; Terao T
    Int J Cancer; 2004 Nov; 112(3):519-24. PubMed ID: 15382080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor.
    Kennedy AR; Beazer-Barclay Y; Kinzler KW; Newberne PM
    Cancer Res; 1996 Feb; 56(4):679-82. PubMed ID: 8630994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor.
    Witschi H; Kennedy AR
    Carcinogenesis; 1989 Dec; 10(12):2275-7. PubMed ID: 2591017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR
    Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
    Billings PC; St Clair W; Owen AJ; Kennedy AR
    Cancer Res; 1988 Apr; 48(7):1798-802. PubMed ID: 3280120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.
    Fereidunian A; Sadeghalvad M; Oscoie MO; Mostafaie A
    Arch Med Res; 2014 Aug; 45(6):455-61. PubMed ID: 25014623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW; Donahue JJ; Wan XS
    Nutr Cancer; 1996; 26(2):209-17. PubMed ID: 8875558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.